As one of the most promising biomarkers of axonal injury, elevated blood or cerebrospinal fluid (CSF) concentrations of NfL in PD individuals were found to be associated with greater PD severity, reduced life expectancy, and an increased susceptibility to motor and cognitive impairment [8, 9]. This evidence concerns the gene NEFL and Parkinson disease.